A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports
Crossref DOI link: https://doi.org/10.1007/s40264-016-0409-x
Published Online: 2016-03-05
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hoffman, Keith B.
Dimbil, Mo
Tatonetti, Nicholas P.
Kyle, Robert F.
Text and Data Mining valid from 2016-03-05